King Pharmaceuticals KG Commercial Auto Liability — Year 8
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's commercial auto liability — year 8.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's commercial auto liability — year 8?
- King Pharmaceuticals (KG) reported commercial auto liability — year 8 of 2.3% in Q4 2025.
- What does commercial auto liability — year 8 mean?
- This metric represents the revenue performance of the commercial auto liability insurance line during the eighth year. It reflects the company's ongoing commitment to the commercial vehicle insurance market and its ability to generate consistent premium income. This data is critical for assessing the maturity and sustainability of the segment's financial contributions.